Carvedilol targets human K2P 3.1 (TASK1) K+ leak channels
about
Modulation of K2P 2.1 and K2P 10.1 K(+) channel sensitivity to carvedilol by alternative mRNA translation initiation.TASK1 (K(2P)3.1) K(+) channel inhibition by endothelin-1 is mediated through Rho kinase-dependent phosphorylationPKC-dependent activation of human K(2P) 18.1 K(+) channels.Breathing Stimulant Compounds Inhibit TASK-3 Potassium Channel Function Likely by Binding at a Common Site in the Channel Pore.Mechanisms of zolpidem-induced long QT syndrome: acute inhibition of recombinant hERG K(+) channels and action potential prolongation in human cardiomyocytes derived from induced pluripotent stem cellsCardiac potassium channel subtypes: new roles in repolarization and arrhythmia.The role of acid-sensitive two-pore domain potassium channels in cardiac electrophysiology: focus on arrhythmias.Novel ion channel targets in atrial fibrillation.Functional characterization of zebrafish K2P18.1 (TRESK) two-pore-domain K+ channels.Novel electrophysiological properties of dronedarone: inhibition of human cardiac two-pore-domain potassium (K2P) channels.
P2860
Q34953291-95FA124B-BCA6-4B12-980A-A2AD5397A858Q36024931-702640C9-8B59-4587-A565-360131512B38Q36159243-A5295E15-FD8D-45B9-BA10-E4C55F628289Q36186112-87276033-A1CF-4D77-B611-1AF055BC2BC1Q36675819-BC2060BD-098E-45DE-9233-777AA46E7FD5Q38201409-9138D4A8-FA6B-472E-8B78-EF1A7C43A867Q38268975-057E008B-C3CD-4C18-8738-43FB3648AB28Q38751315-E6D1C6C2-32B2-4DF5-A824-EEC5E3AACD08Q42631828-5392EAA3-3AC9-4E76-A607-E142028453B4Q48644420-F8DFE36E-4B64-4C22-9BEF-3A45D2922A28
P2860
Carvedilol targets human K2P 3.1 (TASK1) K+ leak channels
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Carvedilol targets human K2P 3.1 (TASK1) K+ leak channels
@ast
Carvedilol targets human K2P 3.1 (TASK1) K+ leak channels
@en
type
label
Carvedilol targets human K2P 3.1 (TASK1) K+ leak channels
@ast
Carvedilol targets human K2P 3.1 (TASK1) K+ leak channels
@en
prefLabel
Carvedilol targets human K2P 3.1 (TASK1) K+ leak channels
@ast
Carvedilol targets human K2P 3.1 (TASK1) K+ leak channels
@en
P2093
P2860
P1476
Carvedilol targets human K2P 3.1 (TASK1) K+ leak channels
@en
P2093
I Staudacher
J Kisselbach
K Staudacher
P2860
P304
P356
10.1111/J.1476-5381.2011.01319.X
P407
P577
2011-07-01T00:00:00Z